OCRA is the voice for the ovarian cancer community, engaging with policymakers to help deliver critical research funding and access to care. Learn about our policy positions and join us.
This shortage of chemotherapy drugs, including cisplatin and carboplatin, has reached a serious level, impacting the treatment options available to some ovarian cancer patients. But you can help…
As many are aware, the United States is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential in the treatment of ovarian cancer…
We hope you’re feeling the love from the teal community this week, and always. We’re just seven weeks into 2023 and there’s so much to share — new grantees, a new website, and a bold…
I’ve always felt you have a duty to speak up. And if we don’t, who will? Who will speak up for our loved ones, and for all the women?